Filippi, M., Danesi, R., Derfuss, T., Duddy, M., Gallo, P., Gold, R., . . . Trojano, M. (2022). Early and unrestricted access to high-efficacy disease-modifying therapies: A consensus to optimize benefits for people living with multiple sclerosis. Journal of neurology, 269(3), 1670-1677. https://doi.org/10.1007/s00415-021-10836-8
Citace podle Chicago (17th ed.)Filippi, Massimo, et al. "Early and Unrestricted Access to High-efficacy Disease-modifying Therapies: A Consensus to Optimize Benefits for People Living with Multiple Sclerosis." Journal of Neurology 269, no. 3 (2022): 1670-1677. https://doi.org/10.1007/s00415-021-10836-8.
Citace podle MLA (9th ed.)Filippi, Massimo, et al. "Early and Unrestricted Access to High-efficacy Disease-modifying Therapies: A Consensus to Optimize Benefits for People Living with Multiple Sclerosis." Journal of Neurology, vol. 269, no. 3, 2022, pp. 1670-1677, https://doi.org/10.1007/s00415-021-10836-8.